Meningitic Escherichia coli is the major etiological agent of bacterial meningitis in neonatal stage, which is a life-threatening infection disease with severe neurological sequelae and high mortality. Blood-brain barrier (BBB) disruption is an important hallmark during this infection. Here, we showed that astrocyte-derived TGFβ1 maintained the BBB integrity via activating hedgehog signaling in endothelium, while meningitic E. coli infection could effectively subvert BBB by attenuating TGFBRII/Gli2-mediated such signaling. By high-throughput screening, we demonstrated E. coli α-hemolysin was the key determinant responsible for this attenuation through Sp1-dependent TGFBRII reduction, as well as triggering Ca2+ influx and protein kinase A activation, thus leading to Gli2 suppression. Additionally, the exogenous hedgehog agonist SAG showed a promising protection against meningitic E. coli-caused BBB dysfunction. Our work revealed a hedgehog-involved mechanism of E. coli-caused BBB disruption, and suggested that activating hedgehog signaling could be a potential protective strategy for future therapy of bacterial meningitis.
Fu, Jiyang and Li, Liang and Huo, Dong and Zhi, Shuli and Yang, Ruicheng and Yang, Bo and Xu, Bojie and Zhang, Tao and Dai, Menghong and Tan, Chen and Chen, Huanchun and Wang, Xiangru, Meningitic
Escherichia Coli α-Hemolysin Facilitates Blood-Brain Barrier Disruption Via Targeting Tgfβ1-Induced Hedgehog Signaling. Available at SSRN: https://ssrn.com/abstract=3569538 or http://dx.doi.org/10.2139/ssrn.3569538
This version of the paper has not been formally peer reviewed.